APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese

被引:32
|
作者
Chien, Kuo-Liong [2 ]
Fang, Woei-Horng [1 ]
Wen, Hui-Chin [1 ]
Lin, Hsing-Pei [1 ]
Lin, Yen-Lin [1 ]
Lin, Shu-Wha [1 ]
Wu, June-Hsieh
Kao, Jau-Tsuen [1 ,3 ]
机构
[1] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Publ Sch, Inst Prevent Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
关键词
apolipoprotein A1/C3/A5; triglyceride; HDL cholesterol; haplotype;
D O I
10.1016/j.cca.2007.12.014
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Apolipoprotein A5 gene (APOA5) has been shown to modulate plasma triglyceride concentrations. We investigated 2 distinct APOA1/C3/A5 haplotypes roles for hypertriglyceridemia. Methods: We recruited 308 cases of hypertriglyceridemia and 281 normal controls from a hospital. Twelve single nucleotide polymorphisms (SNPs) across the APOA1/C3/A5 gene region were genotyped. Results: One haplotype containing the minor alleles of the APOA5 (-1131T>C, c.553G>T) and APOA1 (-3013C>T,-75G>A) was more prevalent in cases than in controls (11.3% vs. 1.1%, respectively) and was statistically significantly associated with high triglycerides (adjusted odds ratio: 12.83, 95% confidence interval [CI]: 5.1-32.4, P<0.001). Another haplotype that was associated with hypertriglyceridemia (adjusted odds ratio 2.13, 95% CI, 1.37-3.29, P=0.001). Participants carrying both minor alleles of APOA5-1131CC and c.553TT had a 116% higher triglyceride concentration compared with those carrying common allele. Conclusions: The APOA1/C3/A5 haplotype represents an important locus for predicting risk of hypertriglyceridemia among Taiwanese. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 50 条
  • [21] APOA1/C3/A4/A5 Gene Cluster at 11q23.3 and Lipid Metabolism Disorders: From Epigenetic Mechanisms to Clinical Practices
    Xiao, Qianqian
    Wang, Jing
    Wang, Luyun
    Ding, Hu
    BIOMEDICINES, 2024, 12 (06)
  • [22] APOA1/A5 Variants and Haplotypes as a Risk Factor for Obesity and Better Lipid Profiles in a Brazilian Elderly Cohort
    Chen, Elizabeth Suchi
    Furuya, Tatiane Katsue
    Mazzotti, Diego Robles
    Ota, Vanessa Kiyomi
    Cendoroglo, Maysa Seabra
    Ramos, Luiz Roberto
    Araujo, Lara Quirino
    Burbano, Rommel Rodriguez
    Cardoso Smith, Marilia de Arruda
    LIPIDS, 2010, 45 (06) : 511 - 517
  • [23] The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study
    Hsu, Mei-Chi
    Lee, Kuo-Ting
    Hsiao, Wei-Chiang
    Wu, Chih-Hsing
    Sun, Hung-Yu
    Lin, I-Ling
    Young, Kung-Chia
    BMC CANCER, 2013, 13
  • [24] The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study
    Mei-Chi Hsu
    Kuo-Ting Lee
    Wei-Chiang Hsiao
    Chih-Hsing Wu
    Hung-Yu Sun
    I-Ling Lin
    Kung-Chia Young
    BMC Cancer, 13
  • [25] Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the Genetics of Lipid-Lowering Drugs and Diet Network study
    Liu, Yongjun
    Ordovas, Jose M.
    Gao, Guimin
    Province, Michael
    Straka, Robert J.
    Tsai, Michael Y.
    Lai, Chao-Qiang
    Zhang, Kui
    Borecki, Ingrid
    Hixson, James E.
    Allison, David B.
    Arnett, Donna K.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (02): : 161 - 169
  • [26] APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children
    De França, E
    Alves, JGB
    Hutz, MH
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (04) : 535 - 541
  • [27] Tissue-specific DNA methylation profiles regulate liver-specific expression of the APOA1/C3/A4/A5 cluster and can be manipulated with demethylating agents on intestinal cells
    Guardiola, Montse
    Oliva, Iris
    Guillaumet, Amy
    Martin-Trujillo, Alex
    Rosales, Roser
    Carles Vallve, Joan
    Sabench, Fatima
    del Castillo, Daniel
    Zaina, Silvio
    Monk, David
    Ribalta, Josep
    ATHEROSCLEROSIS, 2014, 237 (02) : 528 - 535
  • [28] Resequencing the Apo lipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia
    Evans, D.
    Aberle, J.
    Beil, F. U.
    ATHEROSCLEROSIS, 2011, 219 (02) : 715 - 720
  • [29] The -1131T&gt;C polymorphism in the apolipoprotein A5 gene is related to hypertriglyceridemia in Taiwanese aborigines
    Huang, Meng-Chuan
    Wang, Tsu-Nai
    Wang, Huan-Sen
    Sung, Yi-Ching
    Ko, Ying-Chin
    Chiang, Hung-Che
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2008, 24 (04): : 171 - 178
  • [30] APOLIPOPROTEIN A1/C3/A5 HAPLOTYPES AND SERUM LIPID LEVELS
    Yin, Rui-Xing
    Li, Yi-Yang
    Lai, Chao-Qiang
    HEART, 2011, 97